The first serious shortage protocol (SSP), issued to combat antidepressant shortages, is to expire tomorrow (25 October) now that stock has returned to ‘sufficient’ levels, the Pharmaceutical Services Negotiating Committee (PSNC) has announced.
The Government authorised its first three SSPs earlier this month (3 October), allowing community pharmacists in England to supply an alternative strength or formulation of the antidepressant fluoxetine to patients who had a prescription for the 10mg, 30mg and 40mg capsules.
In July, legislation came into force that allows community pharmacists in England to provide appropriate alternatives to patients in the event of serious medicine shortages without having to go back to the patient’s GP for an updated script.
Related Article: Pharmacy First gateway changes to help increase payments
PSNC said today (24 Ocotber): ‘Following the successful implementation of SSP01, the Department of Health and Social Care (DHSC) has announced that sufficient stock of fluoxetine 10mg capsules is now available to supply normal demand; as a result the SSP01 for Fluoxetine 10mg capsules is being withdrawn from 23.55 Friday 25th October 2019.
‘Any prescriptions for fluoxetine 10mg capsules after this date must be dispensed in accordance with the prescription, as the SSP will no longer be valid for use.’
Other SSPs still in place
Related Article: ‘Precautionary’ recall of breast cancer medication batch
The SSPs for fluoxetine 30mg capsules and 40mg capsules remain in place and are currently due to expire on 31st October 2019, PSNC said.
The negotiator added: ‘This expiry date may be brought forward or extended, and the content may be amended throughout this period.
Related Article: Customer complaint prompts recall of Omeprazole oral solution batch
‘Pharmacists should ensure they are using the current version of an SSP before supplying an alternative product.’
Up-to-date versions of SSPs can be found on the dedicated NHS Business Services Authority (NHSBSA) website.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.